PLEURAL DISEASES MARKET ANALYSIS

Pleural Diseases Market, By Disease Type (Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, and Others), By Diagnostic Tools (Imaging Techniques, Molecular Diagnostics, Thoracoscopy, and Pleuroscopy), By Treatment Modalities (Medications, Thoracentesis and Pleurodesis, Minimally Invasive Interventions, and Surgical Interventions), By End User (Hospitals and Clinics, Diagnostic Centers, and Research and Academic Institutions), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI6038
Pages :165
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Leading Companies

Top Companies in Global Pleural Diseases Market

Bristol Myers Squibb
Merck & Co., Inc.
GlaxoSmithKline plc
Boehringer Ingelheim International GmbH
Sanofi
AbbVie Inc.
B. Braun SE
Becton, Dickinson and Company
Bicakcilar
Biometrix
Cook Medical
Grena
Redax
Rocket Medical
Smith Medical

Companies covered:

Bristol Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Sanofi, AbbVie Inc., B. Braun SE, Becton, Dickinson and Company, Bicakcilar, Biometrix, Cook Medical, Grena, Redax, Rocket Medical, Smith Medical.

Pleural Diseases Market Report Snapshots

PLEURAL DISEASES MARKET ANALYSIS

Leading Companies

EXISTING CLIENTELE